Longevity science has exploded in the past decade, moving from the fringes of gerontology into mainstream medicine and attracting billions in investment. The field has produced genuine insights — and an enormous amount of hype. Here is an honest assessment of where the science stands in 2026.
The Biology of Aging
Aging is not a single process but a collection of interconnected biological changes. The "hallmarks of aging" framework, first published in 2013 and updated in 2023, identifies 12 core mechanisms:
- Genomic instability (DNA damage accumulation)
- Telomere attrition (shortening of chromosome caps)
- Epigenetic alterations (changes in gene expression patterns)
- Loss of proteostasis (protein quality control failure)
- Disabled macroautophagy (cellular cleanup impairment)
- Deregulated nutrient sensing (mTOR, insulin/IGF-1 pathway dysregulation)
- Mitochondrial dysfunction
- Cellular senescence (accumulation of dysfunctional "zombie cells")
- Stem cell exhaustion
- Altered intercellular communication (chronic inflammation)
- Chronic inflammation ("inflammaging")
- Dysbiosis (gut microbiome disruption)
Most longevity interventions target one or more of these hallmarks. The challenge is that they are deeply interconnected — intervening in one often affects others in unpredictable ways.
What Has Strong Evidence
Caloric Restriction and Fasting
Caloric restriction extends lifespan in virtually every organism studied, from yeast to mice. The CALERIE trial — the most rigorous human caloric restriction study — found that 25% caloric restriction over two years improved multiple biomarkers of aging including insulin sensitivity, blood pressure, inflammation, and thyroid function. Whether it extends human lifespan is unknown, but the metabolic benefits are well-established.
Time-restricted eating and intermittent fasting activate many of the same pathways as caloric restriction — particularly autophagy and mTOR inhibition — with less adherence difficulty.
Exercise
Exercise is the most evidence-backed longevity intervention available. It addresses multiple hallmarks simultaneously: reduces chronic inflammation, improves mitochondrial function, activates autophagy, maintains muscle stem cell function, and improves insulin sensitivity. VO2 max — improved by aerobic exercise — is the single strongest predictor of longevity in the research literature. Resistance training preserves muscle mass and bone density, reducing frailty risk in later life.
Sleep
Chronic sleep deprivation accelerates multiple aging hallmarks. During sleep, the glymphatic system clears amyloid beta and tau proteins from the brain — the same proteins that accumulate in Alzheimer's disease. People sleeping less than 6 hours consistently show accelerated epigenetic aging, higher inflammatory markers, and increased all-cause mortality risk.
Promising but Unproven Interventions
Rapamycin
Rapamycin (an mTOR inhibitor) is the most reproducible life-extension drug in animal models, extending lifespan in mice by 10-25% even when started late in life. Human trials are underway but results are years away. Some longevity physicians are prescribing it off-label; the risk-benefit calculation in healthy humans is genuinely unknown.
Senolytics
Senolytic drugs — which selectively clear senescent "zombie cells" — have shown remarkable results in animal models, reversing multiple age-related conditions. The combination of dasatinib and quercetin is the most studied. Early human trials show safety and some biomarker improvements, but clinical efficacy data in humans is limited.
NAD+ Precursors
NAD+ levels decline with age, and supplementation with precursors like NMN and NR raises NAD+ levels in humans. Animal studies show impressive results; human trials show NAD+ restoration but limited evidence of clinical benefit so far. The supplements are safe and widely used; whether they meaningfully affect aging in humans remains an open question.
What Is Mostly Hype
The longevity supplement market is worth billions and largely outpaces the evidence. Most "anti-aging" supplements have minimal human data. Resveratrol, despite early excitement, has failed to show consistent benefits in human trials. Most "longevity" blood tests marketed directly to consumers measure biomarkers with limited predictive validity for individual outcomes.
The most important longevity interventions remain unglamorous: not smoking, maintaining healthy weight, exercising regularly, sleeping adequately, managing stress, and maintaining social connections. These account for the vast majority of the variance in healthy lifespan across populations.
Practical Takeaways for 2026
- Maximize VO2 max through regular aerobic exercise — the single highest-leverage longevity intervention
- Maintain muscle mass through resistance training — sarcopenia is a major driver of late-life frailty
- Prioritize sleep quality and duration
- Eat a diet high in fiber and polyphenols, low in ultra-processed foods
- Manage chronic stress — it accelerates multiple aging hallmarks
- Stay socially connected — social isolation is as damaging as smoking 15 cigarettes per day by some estimates